alosetron vs linaclotide
Side-by-side comparison of alosetron and linaclotide Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
Lotronex
Linzess
Alosetron (Lotronex) is a medicine for women with severe diarrhea-predominant irritable bowel syndrome (IBS). It helps to reduce diarrhea and stomach pain.
Linzess is a medicine that helps treat certain bowel problems. It works by helping your bowels move more regularly.
Alosetron is used to treat severe diarrhea-predominant irritable bowel syndrome (IBS) in women. It is for women whose IBS symptoms have lasted for 6 months or longer. You should have already ruled out other possible causes of your symptoms. This medicine is only for you if other treatments have not worked well enough.
Linzess is used to treat irritable bowel syndrome with constipation (IBS-C) in adults and children ages 7 and older. It also treats chronic idiopathic constipation (CIC) in adults. Linzess can also treat functional constipation (FC) in children ages 6 and older.
Alosetron blocks a substance called serotonin in your gut. Serotonin can speed up bowel movements. By blocking serotonin, alosetron slows down your bowel and reduces diarrhea.
Linzess is a guanylate cyclase-C agonist. It works by increasing fluid in your intestines. This helps to soften stool and make bowel movements easier.
- • Constipation
- • Abdominal discomfort and pain
- • Nausea
- • Gastrointestinal discomfort and pain
- • Diarrhea
- • Abdominal pain
- • Gas
- • Bloating
- • Viral gastroenteritis
- Medicine not working 11
- Diarrhea 10
- Feeling sick to your stomach 8
- Using the medicine for something it's not approved for 7
- Stomach pain 6
- Diarrhea 4,502
- The medicine is not working 4,365
- Using the medicine for something it's not approved for 3,216
- Constipation 1,862
- Feeling sick to your stomach 1,373
Alosetron can cause serious gut problems, like ischemic colitis (reduced blood flow to the bowel) and severe constipation. These problems can lead to hospitalization, surgery, or even death. Stop taking alosetron right away if you get constipated or have symptoms of ischemic colitis, like bloody diarrhea or bad stomach pain. Call your doctor immediately.
Linzess can cause serious dehydration in children under 2 years old. Do not give Linzess to children under 2 years old. It is also not for people with a known or suspected blockage in their intestines.
It is not known if alosetron can harm your unborn baby. Talk to your doctor if you are pregnant or plan to become pregnant. It is also not known if alosetron passes into breast milk. Talk to your doctor about the best way to feed your baby if you take alosetron.
It is not expected that Linzess will harm your unborn baby. Linaclotide was not found in breast milk, so it is not expected to harm a breastfeeding baby.
Also Compare — Nearby Drugs
Compare linaclotide with
How to Read This alosetron vs linaclotide Comparison
alosetron is classified in the 5-HT3 Antagonist (IBS-D) drug class, while linaclotide sits within the Guanylate Cyclase-C Agonist class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, alosetron has 42 submissions while linaclotide has 15,318. Those figures reflect cumulative reporting volume — not per-patient risk — so older, widely dispensed drugs typically look worse on count alone. No direct interaction between these two drugs is listed in our FDA-derived dataset, though co-prescription still warrants pharmacist review. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot substitute for clinical judgment. Effectiveness, tolerability, drug-drug interactions with your other medications, kidney and liver function, pregnancy status, insurance formulary, and price all feed into a decision that only a licensed prescriber can make responsibly. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This page is for educational purposes only, is not medical advice, and should not be used to self-switch between alosetron and linaclotide — always consult your physician or pharmacist first.
Important: This comparison is for informational purposes only. Drug effects vary between individuals. Always consult your doctor or pharmacist for personalized medical advice.